Tl-118

· Tiltan Pharma Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tl-118, covering 2016-02-05 to 2016-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment [Phase 2]

See pricing